Ryan Langston
Stock Analyst at TD Cowen
(1.17)
# 3,836
Out of 4,690 analysts
256
Total ratings
46.7%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PIII P3 Health Partners | Maintained: Hold | $13 | $10.35 | +25.60% | 12 | Aug 27, 2026 | |
| EHC Encompass Health | Rated: Buy | $125 → $140 | $121.44 | +15.28% | 3 | Aug 10, 2026 | |
| DVA DaVita | Upgraded: Buy | $201 → $220 | $180.93 | +21.60% | 12 | Aug 7, 2026 | |
| AGL agilon health | Maintained: Hold | $55 → $95 | $98.13 | -3.19% | 11 | Aug 7, 2026 | |
| ADUS Addus HomeCare | Rated: Buy | $131 | $122.15 | +7.25% | 23 | Aug 4, 2026 | |
| ALHC Alignment Healthcare | Rated: Buy | $25 → $21 | $14.35 | +46.34% | 10 | Aug 3, 2026 | |
| HUM Humana | Rated: Hold | $350 → $370 | $401.68 | -7.89% | 16 | Jul 31, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Buy | $36 | $32.51 | +10.74% | 16 | Jul 30, 2026 | |
| CNC Centene | Rated: Hold | $65 | $66.93 | -2.88% | 18 | Jul 30, 2026 | |
| UHS Universal Health Services | Rated: Buy | $197 | $178.30 | +10.49% | 17 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $431 | $428.08 | +0.68% | 16 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $200 | $206.37 | -3.09% | 19 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $233 → $263 | $275.98 | -4.70% | 9 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $430 | $405.54 | +6.03% | 18 | Jul 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $465 | $407.48 | +14.12% | 15 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $50 | $38.00 | +31.58% | 13 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $14.21 | +19.68% | 11 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $21.48 | +39.66% | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $391 → $333 | $284.27 | +17.14% | 4 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $12.36 | n/a | 1 | Aug 9, 2024 |
P3 Health Partners
Aug 27, 2026
Maintained: Hold
Price Target: $13
Current: $10.35
Upside: +25.60%
Encompass Health
Aug 10, 2026
Rated: Buy
Price Target: $125 → $140
Current: $121.44
Upside: +15.28%
DaVita
Aug 7, 2026
Upgraded: Buy
Price Target: $201 → $220
Current: $180.93
Upside: +21.60%
agilon health
Aug 7, 2026
Maintained: Hold
Price Target: $55 → $95
Current: $98.13
Upside: -3.19%
Addus HomeCare
Aug 4, 2026
Rated: Buy
Price Target: $131
Current: $122.15
Upside: +7.25%
Alignment Healthcare
Aug 3, 2026
Rated: Buy
Price Target: $25 → $21
Current: $14.35
Upside: +46.34%
Humana
Jul 31, 2026
Rated: Hold
Price Target: $350 → $370
Current: $401.68
Upside: -7.89%
Acadia Healthcare Company
Jul 30, 2026
Reiterated: Buy
Price Target: $36
Current: $32.51
Upside: +10.74%
Centene
Jul 30, 2026
Rated: Hold
Price Target: $65
Current: $66.93
Upside: -2.88%
Universal Health Services
Jul 29, 2026
Rated: Buy
Price Target: $197
Current: $178.30
Upside: +10.49%
Jul 27, 2026
Rated: Buy
Price Target: $431
Current: $428.08
Upside: +0.68%
Jul 27, 2026
Rated: Hold
Price Target: $230 → $200
Current: $206.37
Upside: -3.09%
Jul 27, 2026
Rated: Buy
Price Target: $233 → $263
Current: $275.98
Upside: -4.70%
Jul 19, 2026
Maintained: Hold
Price Target: $430
Current: $405.54
Upside: +6.03%
Jul 17, 2026
Reiterated: Buy
Price Target: $400 → $465
Current: $407.48
Upside: +14.12%
Jul 14, 2026
Rated: Buy
Price Target: $45 → $50
Current: $38.00
Upside: +31.58%
May 27, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $14.21
Upside: +19.68%
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $21.48
Upside: +39.66%
Feb 4, 2026
Reiterated: Buy
Price Target: $391 → $333
Current: $284.27
Upside: +17.14%
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $12.36
Upside: n/a